Recent research has illustrated that the TIGIT-NECTIN2 pathway drives immune cells toward an immunosuppressive and exhausted state in hepatocellular carcinoma [69] and breast cancer [70]. The gene discussed is NECTIN2; the disease is hepatocellular carcinoma.